EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients

Alaa Atamna, Dafna Yahav, Cédric Hirzel

Transplant International · 17.11.2023 · 36

DOI: 10.3389/ti.2023.11856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 17.11.2023. Verfasst von Alaa Atamna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Gammaherpesvirinae, Herpesviridae Infections, Lymphoproliferative Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term risk for malignancy is higher among solid organ transplant (SOT) recipients compared to the general population. Four non-hepatitis viruses have been recognized as oncogenic in SOT recipients—EBV, cause of EBV-associated lymphoproliferative diseases; human herpes virus 8 (HHV8), cause of Kaposi sarcoma, primary effusion lymphoma and multicentric Castleman disease; human papilloma virus, cause of squamous cell skin cancers, and Merkel cell polyomavirus, cause of Merkel cell carcinoma. Two of these viruses (EBV and HHV8) belong to the human herpes virus family. In this review, we will discuss key aspects regarding the clinical presentation, diagnosis, treatment, and prevention of diseases in SOT recipients associated with the two herpesviruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanGammaherpesvirinaeHerpesviridae InfectionsLymphoproliferative DisordersOrgan TransplantationEpstein-Barr Virus InfectionsHumansHerpesvirus 4, HumanTransplant Recipients

Stichwörter der Autor:innen

Epstein-Barr virusKaposi sarcomahuman herpes virus 8multicentic Castleman diseaseposttransplant lymphoproliferative disordersprimary effusion lymphoma

Autor:innen und Institutionen

  • Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
  • Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel.
  • Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Zitieren

APA

Atamna, A., Yahav, D., & Hirzel, C. (2023). Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients. Transplant International, 36. https://doi.org/10.3389/ti.2023.11856

Vancouver

Atamna A, Yahav D, Hirzel C. Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients. Transplant International. 2023;36. doi:10.3389/ti.2023.11856

BibTeX
@article{Atamna2023,
  author = {Atamna, Alaa and Yahav, Dafna and Hirzel, Cédric},
  title = {Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients},
  journal = {Transplant International},
  year = {2023},
  volume = {36},
  doi = {10.3389/ti.2023.11856}
}
Kostenlos starten →